New Drugs

Brand/Generic Company Description
Akynzeo
fosnetupitant/palonosetron
Click here for more information
Helsinn

An injectable formulation for prevention of chemo-induced nausea and vomiting.

Biktarvy
bictegravir/ emtricitabine/tenofovir alafenamide
Click here for more information
Gilead Sciences

A combination drug for treatment of HIV-1 infection.

Crysvita
burosumab-twza
Click here for more information
Ultragenyx

A fibroblast growth factor 23 blocking antibody for X-linked hypophosphatemia.

Erleada
apalutamide
Click here for more information
Janssen

An androgen receptor inhibitor for non-metastatic, castration-resistant prostate cancer.

Ilumya
tildrakizumab-asmn
Click here for more information
Merck

An interleukin-23 antagonist for moderate-to-severe plaque psoriasis.

Lutathera
lutetium Lu 177 dotatate
Click here for more information
Advanced Accelerator Applic.

A radiopharmaceutical for gastroenteropancreatic neuroendocrine tumors.

Symdeko
tezacaftor/ivacaftor
Click here for more information
Vertex Pharm.

A combination formulation for cystic fibrosis in patients with a specific gene mutation.

Tavalisse
fostamatinib
Click here for more information
Rigel Pharm.

A kinase inhibitor for chronic immune thrombocytopenia.

Trogarzo
ibalizumab-uiyk
Click here for more information
Thera Technologies

An antiretroviral for patients with multidrug resistant HIV-1 infection.

Brand/Generic Company Description
Apadaz
benzhydrocodone/acetaminophen
Click here for more information
KemPharm

New combination formulation for short-term management of acute pain.

Cimduo
lamivudine/tenofovir disoproxil fumarate
Click here for more information
Mylan

New combination formulation for HIV-1 infection.

Dexycu
dexamethasone
Click here for more information
Icon Bioscience

New intraocular suspension formulation for postoperative inflammation.

Firvanq
vancomycin
CurtisPharma

An oral solution formulation for C. difficile-associated diarrhea and enterocolitis caused by S. aureus (including MRSA).

Jynarque
tolvaptan
Otsuka America

New formulation of tolvaptan to slow kidney function decline in patients at risk of progressing autosomal dominant polycystic kidney disease.

Osmolex ER
amantadine
Click here for more information
Vertical Pharm.

New extended-release tablet formulation.

Plenvu
PEG 3350 plus electrolytes
Click here for more information
Norgine

A lower-volume, 1-liter bowel prep for colonoscopies.

Symfi
efavirenz/lamivudine/tenofovir disoproxil fumarate
Click here for more information
Mylan

New combination formulation for HIV-1 infection. Contains a higher strength of efavirenz/tablet vs Symfi Lo.

Symfi Lo
efavirenz/lamivudine/tenofovir disoproxil fumarate
Click here for more information
Mylan

New combination formulation for HIV-1 infection.

Ztlido
lidocaine
Click here for more information
Scilex Pharm.

New topical patch formulation for post-herpetic neuralgia pain.

Brand/Generic Company Description
Zinbryta
Daclizumab
Click here for more information
Biogen/AbbVie

The manufacturer is removing the drug from the worldwide market due to safety concerns, including reports of severe liver damage and immune-related conditions.